Frequency and outcomes of STEMI patients presenting between 12 and 24h after symptom onset: Late-presenting STEMI

Anna C Gonzalez Griffin1, Mehmet Yildiz2, Steven Bradley1

  • 1Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Insights

Outcomes for ST-elevation myocardial infarction (STEMI) patients presenting 12-24 hours after symptom onset were similar to earlier presenters. Despite unfavorable risk profiles, late STEMI presenters showed comparable in-hospital and 1-year mortality rates.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Public Health

Background:

  • Previous studies on primary percutaneous coronary intervention (PCI) for late STEMI have yielded inconsistent results.
  • Most prior randomized trials were conducted during the fibrinolytic era, predating widespread PCI adoption.

Purpose of the Study:

  • To evaluate the characteristics and prognosis of ST-elevation myocardial infarction (STEMI) patients presenting 12-24 hours after symptom onset.
  • To assess outcomes in contemporary US regional STEMI systems of care for these late presenters.

Main Methods:

  • A two-center registry-based cohort study included 5427 STEMI patients from March 2003 to December 2020.
  • Patients were stratified by symptom onset to balloon time: <3, 3-6, 6-12, and 12-24 hours (late presenters).
  • Clinical characteristics, revascularization rates, door-to-balloon times, and mortality were analyzed.

Main Results:

  • Late presenters (6.2% of cohort, rising to 11% during early COVID-19) were more likely to be older, female, and have hypertension and diabetes.
  • Late presenters had longer median door-to-balloon times and were less likely to undergo PCI.
  • In-hospital and 1-year mortality risks were similar between late presenters and those presenting within 12 hours.

Conclusions:

  • Despite higher risk profiles and delays in treatment, late STEMI presenters had comparable clinical outcomes to earlier presenters.
  • Contemporary STEMI systems of care appear to mitigate the negative prognostic impact of delayed presentation.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
56
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
34
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
22
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
19
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
24